AI Startup Brellium Secures $16.7M to Revolutionize Medical Chart Reviews

Brellium, a startup specializing in artificial intelligence-powered medical chart reviews, has successfully raised $16.7 million in series A funding. The investment round, led by First Round Capital and Left Lane Capital, aims to scale up the company's innovative solution for automating clinical quality and payer compliance in healthcare providers.

AI-Driven Automation for Healthcare Documentation

Brellium's technology addresses a critical pain point in the healthcare industry: the labor-intensive and error-prone process of manual chart reviews. By leveraging artificial intelligence, the startup has developed a system that proactively audits every patient visit, identifying compliance risks before they become significant issues.

The company's solution provides instant notifications to healthcare providers when charts require corrections, complete with clear instructions on how to address the problems. This approach not only streamlines the documentation process but also enhances the quality of patient care by ensuring critical information is accurately recorded and easily accessible.

Widespread Adoption and Industry Impact

Since its inception, Brellium has rapidly expanded its reach across the healthcare sector. The company now supports 250,000 providers across all 50 states, with a diverse customer base spanning behavioral health, Applied Behavior Analysis (ABA), home health, hospice, weight loss, chronic care management, and primary care.

Notable clients include prominent names in the healthcare industry such as Grow Therapy, Rula, Headspace, Hopebridge, Lightfully Behavioral Health, and Talkiatry. This broad adoption underscores the pressing need for efficient, accurate medical documentation processes across various healthcare specialties.

Funding Allocation and Future Growth

The newly secured $16.7 million in funding will be strategically allocated to fuel team growth, product development, and broader adoption across healthcare industries. Brellium has identified mental health, weight loss, autism, and hospice care as key areas for expansion.

Zach Rosen, co-founder of Brellium, emphasized the company's commitment to improving healthcare outcomes, stating, "In the unlikely event a payor claws back reimbursement on a Brellium-approved chart, we'll foot the bill." This guarantee reflects the company's confidence in its AI-driven solution and its potential to significantly reduce errors in medical documentation.